Page 7 - Protein Sciences News Today

Bio-Techne (NASDAQ:TECH – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Tuesday, August 8th. Analysts expect Bio-Techne to post earnings of $0.49 per share for the quarter. Persons that wish to listen to the company’s earnings conference call can do so using this link. Bio-Techne Price Performance […]

Amalgamated Bank reduced its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 5.2% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 57,553 shares of the biotechnology company’s stock after selling 3,185 shares during the quarter. Amalgamated Bank’s holdings in Bio-Techne […]

/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, August 8, 2023, at...

From JEOL USA, Inc.

Covea Finance decreased its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 12.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 44,000 shares of the biotechnology company’s stock after selling 6,400 shares during the period. […]

Leavell Investment Management Inc. lessened its position in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 8.4% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 74,764 shares of the biotechnology company’s stock after selling 6,900 shares during the period. Leavell Investment Management […]

Spence Asset Management decreased its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 0.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 111,666 shares of the biotechnology company’s stock after selling 493 shares during the period. Bio-Techne makes up 2.6% […]

Fred Alger Management LLC boosted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) by 200.8% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,337,191 shares of the biotechnology company’s stock after purchasing an additional 892,681 shares during the period. Fred Alger Management LLC’s holdings in Bio-Techne were worth $110,826,000 at the […]

Eversept Partners LP bought a new stake in Bio-Techne Co. (NASDAQ:TECH – Get Rating) during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 16,635 shares of the biotechnology company’s stock, valued at approximately $1,379,000. Several other hedge funds and other institutional investors also recently modified […]

Eversept Partners LP purchased a new stake in shares of Bio-Techne Co. (NASDAQ:TECH – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 16,635 shares of the biotechnology company’s stock, valued at approximately $1,379,000. Other hedge funds and other institutional […]